Neovasc Inc. Accounts Receivable Change

Accounts Receivable Change of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Accounts Receivable Change growth rates and interactive chart.


Highlights and Quick Summary

  • Accounts Receivable Change for the quarter ending March 31, 2022 was $-25.6 Thousand (a -106.21% decrease compared to previous quarter)
  • Year-over-year quarterly Accounts Receivable Change decreased by -82.86%
  • Annual Accounts Receivable Change for 2021 was $-397 Thousand (a 38.46% increase from previous year)
  • Annual Accounts Receivable Change for 2020 was $-287 Thousand (a 110.86% increase from previous year)
  • Annual Accounts Receivable Change for 2019 was $-136 Thousand (a -171.9% decrease from previous year)
  • Twelve month Accounts Receivable Change ending March 31, 2022 was $-337 Thousand (a -15.9% decrease compared to previous quarter)
  • Twelve month trailing Accounts Receivable Change decreased by -47.14% year-over-year
Trailing Accounts Receivable Change for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
$-337 Thousand $-401 Thousand $-935 Thousand $-638 Thousand
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Accounts Receivable Change of Neovasc Inc.

Most recent Accounts Receivable Changeof NVCN including historical data for past 10 years.

Interactive Chart of Accounts Receivable Change of Neovasc Inc.

Neovasc Inc. Accounts Receivable Change for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-0.03
2021 $0.41 $-0.57 $-0.15 $-0.09 $-0.4
2020 $-0.12 $-0.28 $0.15 $-0.03 $-0.29
2019 $-0.17 $0.02 $0.16 $-0.14 $-0.14
2018 $0.16 $-0.42 $-0.13 $0.59 $0.19
2017 $0.1 $0.14 $0.71 $0.96 $1.98
2016 $-0.2 $-0.98 $-0.13 $-0.04 $-1.36
2015 $-0.47 $0.17 $0.02 $-0.47
2014 $-0.57 $-0.57

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.